JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2007) 192, 313-323       DOI: 10.1677/JOE-06-0021
© 2007 Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bang, A. S
Right arrow Articles by Pemberton, C. J
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bang, A. S
Right arrow Articles by Pemberton, C. J

Characterisation of proghrelin peptides in mammalian tissue and plasma

Angela S Bang, Steven G Soule1, Tim G Yandle, A Mark Richards and Chris J Pemberton

Christchurch Cardioendocrine Research Group, Department of Medicine,
1 Department of Endocrinology, Christchurch School of Medicine and Health Sciences, University of Otago, PO Box 4345, 8140 Christchurch, New Zealand

(Requests for offprints should be addressed to C J Pemberton; Email: chris.pemberton{at}chmeds.ac.nz)

Ghrelin is a 28 amino acid stomach peptide, derived from proghrelin(1–94), that stimulates GH release, appetite and adipose deposition. Recently, a peptide derived from proghrelin(53–75) – also known as obestatin – has been reported to be a physiological antagonist of ghrelin in the rat. Using four specific RIAs, we provide the first characterisation of proghrelin(1–94) peptides in human plasma, their modulation by metabolic manipulation and their distribution in mammalian tissues. ghrelin(1–28) immunoreactivity (IR) in human plasma and rat plasma/stomach consisted of major des-octanoyl and minor octanoylated forms, as determined by HPLC/RIA. Human plasma ghrelin(1–28) IR was significantly suppressed by food intake, oral glucose and 1 mg s.c. glucagon administration. ghrelin(1–28) IR and proghrelin(29–94) IR peptide distributions in the rat indicated that the stomach and gastrointestinal tract contain the highest amounts of the peptides. Human and rat plasma and rat stomach extracts contained a major IR peak of proghrelin(29–94)-like peptide as determined by HPLC/RIA, whereas no obestatin IR was observed. Human plasma proghrelin(29–94)-like IR positively correlated with ghrelin(1–28) IR, was significantly suppressed by food intake and oral glucose and shared with ghrelin(1–28) IR a negative correlation with body mass index. We found no evidence for the existence of obestatin as a unique, endogenous peptide. Rather, our data suggest that circulating and stored peptides derived from the carboxyl terminal of proghrelin (C-ghrelin) are consistent in length with proghrelin(29–94) and respond to metabolic manipulation, at least in man, in similar fashion to ghrelin(1–28).




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
J. V. Zhang, H. Jahr, C.-W. Luo, C. Klein, K. Van Kolen, L. Ver Donck, A. De, E. Baart, J. Li, D. Moechars, et al.
Obestatin Induction of Early-Response Gene Expression in Gastrointestinal and Adipose Tissues and the Mediatory Role of G Protein-Coupled Receptor, GPR39
Mol. Endocrinol., June 1, 2008; 22(6): 1464 - 1475.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Anderwald-Stadler, M. Krebs, M. Promintzer, M. Mandl, M. G. Bischof, P. Nowotny, T. Kastenbauer, A. Luger, R. Prager, and C. Anderwald
Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans
Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1393 - E1398.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society for Endocrinology.